Ogawa, Maiko http://orcid.org/0000-0002-8742-5284
Arihiro, Seiji
Matsuhashi, Nobuyuki
Joh, Takashi
Higuchi, Kazuhide
Iwakiri, Katsuhiko
Kamiya, Takeshi
Manabe, Noriaki
Isshi, Kimio
Nakada, Tatsuya
Hokari, Atsushi
Saruta, Masayuki
Oshio, Atsushi
Haruma, Ken
Nakada, Koji
Funding for this research was provided by:
Takeda Pharmaceutical Company
Otsuka Pharmaceutical
Daiichi-Sankyo
EA Pharma Co., Ltd.
Astrazeneca
Takeda Pharmac
Eisai
Article History
Received: 11 May 2020
Accepted: 18 October 2020
First Online: 2 November 2020
Change Date: 8 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10388-021-00837-x
Compliance with ethical standards
:
: The study was conducted in accordance with the Declaration of Helsinki (sixth revision, 2008), after approval by the ethics committee of each institution or the central ethics committee of Nishi Clinic, Osaka, Japan.
: Dr. Nobuyuki Matsuhashi received a research grant from Astrazeneca, Takeda Pharm., Eizai. Dr. Katsuhiko Iwakiri received Lecture fees from Takeda Pharmaceutical Co., Ltd., Otsuaka Pharmaceutical Co., Ltd., DAIICHI SANKYO COMPANY, LIMITED, and EA Pharma Co., LTD. Dr. Maiko Ogawa, Dr. Seiji Arihiro, Dr. Takashi Joh, Dr. Kazuhide Higuchi, Dr. Takeshi Kamiya, Dr. Noriaki Manabe, Dr. Kimio Isshi, Dr. Tatsuya Nakada, Dr. Atsushi Hokari, Dr. Masayuki Saruta, Dr. Atsushi Oshio, Dr. Ken Haruma and Dr. Koji Nakada declare that they have no conflict of interest.
: Written informed consent was obtained from all enrolled patients.